Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly nab-paclitaxel plus carboplatin for cancer of unknown primary
jRCTs051180084Phase 2Completed
- Start
- Nov 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel and carboplatin in cancer of unknown primary (CUP). Primary endpoint: response rate. Started Nov 2013; status: completed.
02
Drugs
nab-paclitaxelcarboplatin
03
Conditions
cancer of unknown primary (CUP)
Beyond the preview
Go deeper on jRCTs051180084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180084.